Hemophilia B

The US Food and Drug Administration has approved Odactra for the treatment of house dust mite-induced nasal inflammation.

The FDA has approved Xermelo to be used in combination with somatostatin analogue therapy for the treatment of carcinoid syndrome diarrhea.

The FDA has approved Xermelo to be used in combination with somatostatin analogue therapy for the treatment of carcinoid syndrome diarrhea.

The FDA has approved Xermelo to be used in combination with somatostatin analogue therapy for the treatment of carcinoid syndrome diarrhea.

The FDA has approved once-daily Qtern for the treatment of patients with type 2 diabetes, as an adjunct to diet and exercise for the improvement of glycemic control.

The FDA has approved once-daily Qtern for the treatment of patients with type 2 diabetes, as an adjunct to diet and exercise for the improvement of glycemic control.

The FDA has approved once-daily Qtern for the treatment of patients with type 2 diabetes, as an adjunct to diet and exercise for the improvement of glycemic control.

The FDA has approved Spiriva Respimat for long-term, once-daily maintenance treatment of asthma in individuals aged 6 and older.

The FDA has approved Spiriva Respimat for long-term, once-daily maintenance treatment of asthma in individuals aged 6 and older.

The FDA has approved Spiriva Respimat for long-term, once-daily maintenance treatment of asthma in individuals aged 6 and older.